Price
$2.25
Decreased by -5.86%
Dollar volume (20D)
433.30 K
ADR%
9.95
Shares float
4.40 M
Shares short
103.50 K [2.35%]
Shares outstanding
8.61 M
Market cap
27.09 M
Beta
N/A
Price/earnings
N/A
20D range
1.53 2.53
50D range
0.81 2.53
200D range
0.69 9.55

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.

The company operates through Integra and Scienture segments.

The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products.

The Scienture segment researches and develops branded pharmaceutical products.

The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen.

It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia.

Scienture Holdings, Inc. is based in Tampa, Florida.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Apr 21, 25 -0.33
Decreased by -101.59%
-
Mar 25, 25 -0.82
Increased by +93.68%
-
Nov 29, 24 -1.34
Increased by +70.66%
-
Jul 22, 24 -1.30
Increased by +55.02%
-
Apr 24, 24 20.49
Increased by +2.13 K%
-
Mar 25, 24 -12.95
Decreased by -769.07%
-
Oct 25, 23 -4.57
Decreased by -399.78%
-
Aug 21, 23 -2.90
Decreased by -45.90%
-
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 10.26 K
Increased by +N/A%
-3.06 M
Decreased by -114.42%
Decreased by -29.87 K%
Decreased by N/A%
Dec 31, 24 53.08 K
Decreased by -97.74%
-7.16 M
Increased by +38.86%
Decreased by -13.49 K%
Decreased by -2.61 K%
Sep 30, 24 64.86 K
Decreased by -83.47%
-3.18 M
Increased by +9.69%
Decreased by -4.91 K%
Decreased by -446.22%
Jun 30, 24 18.70 K
Decreased by -94.90%
-1.83 M
Increased by +7.14%
Decreased by -9.81 K%
Decreased by -1.72 K%
Mar 31, 24 0.00
Decreased by -100.00%
21.25 M
Increased by +3.23 K%
Increased by +N/A%
Increased by +N/A%
Dec 31, 23 2.35 M
Decreased by -6.98%
-11.72 M
Decreased by -1.17 K%
Decreased by -498.04%
Decreased by -1.26 K%
Sep 30, 23 392.29 K
Decreased by -80.92%
-3.53 M
Decreased by -600.81%
Decreased by -898.61%
Decreased by -3.57 K%
Jun 30, 23 366.53 K
Decreased by -88.82%
-1.97 M
Decreased by -82.22%
Decreased by -538.81%
Decreased by -1.53 K%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY